Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non ‐small‐cell lung cancer (NSCLC)

Chemical Biology&Drug Design, EarlyView.
Source: Chemical Biology and Drug Design - Category: Biology Authors: Source Type: research